Reactive oxidative species generating materials and methods of use
US-9549951-B2 · Jan 24, 2017 · US
US9775901B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9775901-B2 |
| Application number | US-201615377022-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 13, 2016 |
| Priority date | Aug 31, 2012 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Materials capable of delivering stabilized free radicals to targeted treatment sites. The materials comprise semi-crystalline, hydrolytically degradable polymers that are subjected to ionizing radiation to create stabilized free radicals therein. Upon exposure to oxygen containing aqueous media, the materials generate reactive oxidative species which are useful in biological processes.
Opening claim text (preview).
What is claimed is: 1. A method of making a biocompatible material with enhanced reactive oxidative species generation, said method comprising: a. blending at least a first hydrolytically degradable semi-crystalline polymeric material and a second hydrolytically semi-crystalline degradable polymeric material to form a blend, said first polymeric material and said second polymeric material having been subjected to different doses of ionizing radiation; and b. contacting the blend with an oxygen-containing aqueous media to enable production of multi-phasic generation of reactive oxidative species, wherein the first and second polymeric materials have different reactive oxidative species generation profiles, and wherein at least one of said first and second polymeric materials comprises stabilized free radicals. 2. The method of claim 1 , wherein an initial burst of reactive oxidative species production and a subsequent sustained period of reactive oxidative species production occurs upon contacting the blend with the oxygen-containing aqueous media. 3. The method of claim 1 , wherein the first polymeric material has a different hydrolytic degradation rate than the second polymeric material. 4. The method of claim 1 , wherein the first polymeric material has a different degree of crystallinity than the second polymeric material. 5. The method of claim 1 , wherein the first and second polymeric materials each comprise stabilized free radicals. 6. The method of claim 1 , wherein the first polymeric material comprises stabilized free radicals and the second polymeric material does not contain stabilized free radicals. 7. The method of claim 1 , wherein the first polymeric material comprises a different amount of stabilized free radicals than the second polymeric material. 8. The method of claim 1 , wherein at least one of said first and second polymeric materials is bioabsorbable. 9. The method of claim 8 , wherein the bioabsorbable polymer is selected from the group consisting of poly(dioxanone), poly(glycolide), poly(lactide) poly(ε-caprolactone), poly(anhydrides) such as poly(sebacic acid), poly(hydroxyalkanoates) such as poly(3-hydroxybutyrate), copolymers of any of these and combinations thereof. 10. The method of claim 1 , wherein said first and second polymeric materials are each subjected to ionizing radiation at a dose rate less than about 50 kGy. 11. The method of claim 1 , wherein said first and second polymeric materials are subjected to ionizing radiation at a total dose from about 30 kGy to about 50 kGy. 12. The method of claim 1 , wherein the blend further comprises at least one therapeutically active agent. 13. The method of claim 1 , wherein said first and second polymeric materials are subjected to ionizing radiation in an inert atmosphere. 14. A method of making a biocompatible material with enhanced reactive oxidative species generation, said method comprising: a. subjecting a first hydrolytically degradable semi-crystalline polymeric material to a first dose of ionizing radiation; b. subjecting a second hydrolytically semi-crystalline degradable polymeric material to a second dose of ionizing radiation; c. blending said first polymeric material and said second polymeric material to form a blend; and d. contacting the blend with an oxygen-containing aqueous media to enable production of multi-phasic generation of reactive oxidative species, wherein said first dose of ionizing radiation is different from said second dose of ionizing radiation, wherein a total dose of ionizing radiation of said first and second polymeric materials is less than about 50 kGy, and wherein the first and second polymeric materials have different reactive oxidative species generation profiles. 15. The method of claim 14 , wherein at least one of said first polymeric material and said second polymeric material comprises stabilized free radicals. 16. The method of claim 14 , wherein said first polymeric material comprises a different amount of stabilized free radicals than the second polymeric material. 17. The method of claim 14 , wherein a total dose of ionizing radiation of said first and second polymeric materials is from about 30 kGy to about 50 kGy. 18. The method of claim 14 , wherein the first polymeric material has a different hydrolytic degradation rate than the second polymeric material. 19. The method of claim 14 , wherein the first polymeric material has a different degree of crystallinity than the second polymeric material. 20. The method of claim 14 , wherein at least one of said first and second polymeric materials is bioabsorbable.
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Materials at least partially resorbable by the body · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.